Tabimorelin
Tabimorelin (oral nonpeptide growth hormone secretagogue)
N/A Amino Acids · MW: N/A
Amino Acids
N/A
Molecular Weight
N/A
Half-life
Approx. 1-3 h
Research Score
3.9
Studies
20
Storage
Store lyophilized at -20°C, reconstituted at 2-8°C
What is Tabimorelin?
Tabimorelin is an orally active, nonpeptide growth hormone secretagogue developed to activate GH release via the ghrelin receptor. It is one of the better-known oral GH-axis research compounds from the literature.
Key Benefits & Mechanisms
oral GH-axis stimulation
pulsatile secretion research
nonpeptide ghrelin receptor agonism
metabolic-axis modulation
Research Summary
Tabimorelin has been evaluated in human studies as an oral GH secretagogue with measurable increases in circulating GH and IGF-1-related endpoints. Research interest centers on its nonpeptide oral bioavailability and its ability to model GH release without injectable peptides.
Related Peptides
Ibutamoren
Ibutamoren mesylate (MK-677)
Ibutamoren is an orally active ghrelin receptor agonist that increases pulsatile growth hormone and IGF-1 secretion. It has been studied for effects on lean mass, recovery, and age-related anabolic support.
Growth HormoneAnamorelin
Anamorelin hydrochloride (ONO-7643)
Anamorelin is a selective ghrelin receptor agonist developed to stimulate appetite and growth hormone signaling. It has been investigated primarily in cancer cachexia and other wasting states.
Growth HormoneMacimorelin
Macimorelin acetate (AEZS-130)
Macimorelin is an orally active ghrelin mimetic used as a growth hormone stimulation agent. It produces a rapid GH rise after a single dose and is used clinically to help diagnose adult GH deficiency.
Growth HormoneCapromorelin
Capromorelin hydrochloride
Capromorelin is a ghrelin receptor agonist that stimulates growth hormone release and increases appetite. It is best known in veterinary medicine, but it has also been explored in human research settings.
Growth Hormone